SecBot SecBot
DEFA14A ·Filed Apr 22, 2026

DCGO

DocGo Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001213900-26-046603
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the outcome of the Annual Meeting vote on the reverse stock split proposal, as this could impact the company's stock price and trading dynamics. The recent board changes suggest ongoing governance restructuring that may influence future strategic decisions.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
DCGO ▼ -2.54% at T+60d
NEUTRAL call -2.54% · α vs SPY -7.56% · entry $0.6880 → $0.6705
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
+4.36%
call +4.36% · α +3.58%
$0.7180
settled 6mo ago
T+5d
+2.76%
call +2.76% · α +1.28%
$0.7070
settled 6mo ago
T+20d
-10.76%
call -10.76% · α -15.39%
$0.6140
settled 5mo ago
T+60d
-2.54%
call -2.54% · α -7.56%
$0.6705
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

DocGo Inc. has filed a definitive proxy statement (DEFA14A) ahead of its 2026 Annual Meeting, which includes a proposal to approve a reverse stock split at a ratio between 1-for-5 and 1-for-10. This follows recent board changes, including the departure of Dr. Stephen Klasko and the appointment of Michael Burdiek as independent Chair. The proxy filing is part of an ongoing governance process following recent executive changes.

Key Financial Metrics

Vote
director election
Meeting
2026-06-16

Key Facts

  • DocGo Inc. filed DEFA14A for its 2026 Annual Meeting
  • Proposals include election of directors, advisory vote on executive compensation, and a series of reverse stock split options
  • Recent 8-K filing reported departure of board member Dr. Stephen Klasko and appointment of Michael Burdiek as independent Chair
  • Meeting date is June 16, 2026
  • Proxy materials include a proposal to approve a reverse stock split at ratios between 1-for-5 and 1-for-10

Financial Impact

Potential reverse stock split at ratio of 1-for-5 to 1-for-10

stock priceshares outstandingmarket capitalization

Risk Factors

  • Reverse stock split could signal financial distress to investors
  • Potential dilution concerns if reverse split is implemented
  • Board changes may lead to strategic shifts

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-046603
Document: 0001213900-26-046603-index-headers.html0001213900-26-046603
Document: 0001213900-26-046603-index.html0001213900-26-046603
Document: 0001213900-26-046603.txt0001213900-26-046603
6 reports for DCGO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DCGO — sortable, filterable
TypeNow
Oct 5, 2026
22d ago
8-K
MIXED ★ 6/10
$0.3650awaiting T+20—$0.2880 (−21.10%)
Sep 22, 2026
4w ago
Institutional Cluster
BEARISH ★ 4/10
$0.3583 $0.2591▲ +27.69%▲ +27.13%$0.2880 (+19.62%)
May 11, 2026
24w ago
8-K
MIXED ★ 5/10
$0.5950 $0.5560▼ −6.55%▼ −4.83%$0.2880 (−51.60%)
Apr 22, 2026
26w ago
DEFA14A
NEUTRAL ★ 4/10
$0.6880 $0.6140▼ −10.76%▼ −15.39%$0.2880 (−58.14%)
Apr 21, 2026
26w ago
8-K
NEUTRAL ★ 3/10
$0.7360 $0.5670▼ −22.96%▼ −26.13%$0.2880 (−60.87%)
Feb 28, 2026
34w ago
Institutional Cluster
BULLISH ★ 6/10
$0.6900 $0.6000▼ −13.04%▼ −5.11%$0.2880 (−58.26%)
Showing 6 of 6

US Market Status

Market Open — Closes in 5h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026